Internal Medicine, Endocrinology, Diabetes, & Metabolism · New Kensington, PA
NPI
1194016808
Since 2011
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
356 Freeport St
New Kensington, PA, 15068
Phone (724) 367-2400
Groups this clinician bills Medicare through
Medicare paid, 2024
$49K
554 services
Medicare patients, 2024
340
Average age 71
Drug cost, 2024
$1.6M
3,904 prescriptions
Company payments, 2025
$822
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nishit Vaghasia was code 99215 (office e&m - established), 219 times for 154 patients. In total Nishit Vaghasia billed 554 services in 18 codes, and Medicare paid $49K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 219 | 154 | $110.66 | $24K |
| 99214 Office E&M - Established | Office | 138 | 124 | $81.74 | $11K |
| 99232 Hospital E&M - Subsequent | Facility | 76 | 36 | $57.08 | $4,338 |
| 99233 Hospital E&M - Subsequent | Facility | 32 | 19 | $89.58 | $2,867 |
| 99222 Hospital E&M - Initial | Facility | 20 | 20 | $98.56 | $1,971 |
| 99204 Office E&M - New | Office | 13 | 13 | $110.47 | $1,436 |
| 95251 Test - Miscellaneous | Office | 13 | 12 | $26.24 | $341 |
| 83036 Blood Count | Office | 11 | 11 | $9.52 | $105 |
By year: 2023 $18K for 181 services; 2024 $49K for 554 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 11 | 11 | $9.52 | $105 |
Medicare prescription drug claims, 2024
In 2024, the drug Nishit Vaghasia prescribed most often to Medicare patients was Levothyroxine Sodium, with 457 prescriptions and refills. In total Nishit Vaghasia wrote 3,904 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 457 | 1,122 | 133 | $46K |
| Ozempic Semaglutide | 343 | 529 | 86 | $484K |
| Metformin Hcl Er Metformin Hcl | 284 | 698 | 93 | $3,862 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 205 | 495 | 79 | $26K |
| Jardiance Empagliflozin | 140 | 278 | 49 | $155K |
| Mounjaro Tirzepatide | 137 | 188 | 37 | $196K |
| Metformin Hcl Generic | 129 | 349 | 45 | $1,009 |
| Glipizide Er Glipizide | 129 | 328 | 39 | $1,788 |
| Trulicity Dulaglutide | 129 | 183 | 32 | $179K |
| Methimazole Generic | 125 | 261 | 33 | $1,123 |
| Synthroid Levothyroxine Sodium | 97 | 236 | 31 | $7,215 |
| Hydrocortisone Generic | 89 | 168 | 23 | $4,171 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 83 | 214 | 38 | $12K |
| Novolog Flexpen Insulin Aspart | 81 | 138 | 33 | $20K |
| Atorvastatin Calcium Generic | 79 | 235 | 33 | $954 |
Brand drugs: 1,782 claims; generic drugs: 1,871 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nishit Vaghasia $822 ($822 in general payments such as food, travel and fees) from 13 companies. The largest payer was Novo Nordisk Inc with $204.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 12 | $204 |
| Medtronic, Inc. MDT | 4 | $166 |
| Amgen Inc. AMGN | 4 | $95.08 |
| CeQur Corporation | 1 | $63.35 |
| Abbvie Inc. ABBV | 3 | $60.88 |
| Insulet Corporation PODD | 2 | $39.44 |
| Sequel Med Tech, LLC | 1 | $39.08 |
| Ascendis Pharma Endocrinology Inc ASND | 2 | $38.27 |
| Madrigal Pharmaceuticals MDGL | 1 | $30.68 |
| Lilly USA, LLC LLY | 2 | $30.39 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.